Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Product › Details

sHIgM22

	Next higher product group	M1 monoclonal antibody
	Status	2000-06-12 development existent
	Organisation	Acorda Therapeutics Inc. (Nasdaq:ACOR)
	Group	Acorda Therapeutics (Group)

Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for MAb

[1] Novartis AG. (9/11/23). "Press Release: Sandoz Announces Exclusive Deal to Commercialize Biosimilar Ustekinumab". Basel....
[2] BioNTech AG. (3/20/23). "Press Release: BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications". Mainz & Rockville, MD....
[3] TVM Capital Life Science. (2/8/23). "Press Release: TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients". Montréal, QC & Munich....
[4] Evotec SE. (9/20/22). "Press Release: Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense under Accelerated Antibodies Program". Hamburg....
[5] BeiGene, Ltd.. (10/31/19). "Press Release: BeiGene Announces Global Strategic Oncology Collaboration with Amgen". Cambridge, MA & Beijing....
[6] Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen....
[7] Xencor, Inc.. (5/23/19). "Press Release: Xencor Appoints Jeremy Grunstein, Ph.D., as Vice President, Business Development". Monrovia, CA....
[8] Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge....
[9] UCB S.A.. (3/1/19). "Press Release: New Data Affirms Strength of UCB Immuno-Dermatology Portfolio". Brussels....
[10] UCB S.A.. (2/28/19). "Press Release: UCB Full Year Report 2018. 2018 Marks the Fifth Consecutive Year of Profitable Growth, Intensifying Investment in UCB’s Strong Pipeline". Brussels....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]